UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immune-related adverse events with immune checkpoint blockade: a comprehensive review

European journal of cancer (1990), 2016-02, Vol.54, p.139-148

2016

Volltextzugriff (PDF)

Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer

Annals of oncology, 2015-06, Vol.26 (6), p.1223-1229

2015

Volltextzugriff (PDF)

Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours

European journal of cancer (1990), 2017-08, Vol.81, p.81-89

2017

Volltextzugriff (PDF)

Seeking the driver in tumours with apparent normal molecular profile on comparative genomic hybridization and targeted gene panel sequencing: what is the added value of whole exome sequencing?

Annals of oncology, 2016-02, Vol.27 (2), p.344-352

2016

Volltextzugriff (PDF)

Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety

Annals of oncology, 2012-05, Vol.23 (5), p.1301-1306

2012

Volltextzugriff (PDF)

Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy

Lung cancer (Amsterdam, Netherlands), 2015-09, Vol.89 (3), p.306-310

2015

Volltextzugriff (PDF)

Phase II trial of thalidomide in renal-cell carcinoma

Annals of oncology, 2002-07, Vol.13 (7), p.1029-1035

2002

Volltextzugriff (PDF)

Exosomes for cancer immunotherapy

Annals of oncology, 2004-01, Vol.15 (suppl-4), p.iv141-iv144

2004

Volltextzugriff (PDF)

Tumor-derived exosomes: a new source of tumor rejection antigens

Vaccine, 2002-12, Vol.20, p.A28-A31

2002

Volltextzugriff (PDF)

FGFR inhibitor induced peripheral neuropathy in patients with advanced RCC

Annals of oncology, 2010-07, Vol.21 (7), p.1559-1560

2010

Volltextzugriff (PDF)

Cross-Presentation by Dendritic Cells of Tumor Antigen Expressed in Apoptotic Recombinant Canarypox Virus-Infected Dendritic Cells

The Journal of immunology (1950), 2001-08, Vol.167 (3), p.1795-1802

2001

Volltextzugriff (PDF)

Exosomes as Potent Cell-Free Peptide-Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I/Peptide Complexes to Dendritic Cells

The Journal of immunology (1950), 2004-02, Vol.172 (4), p.2126-2136

2004

Volltextzugriff (PDF)

Malignant effusions and immunogenic tumour-derived exosomes

The Lancet (British edition), 2002-07, Vol.360 (9329), p.295-305

2002

Volltextzugriff (PDF)

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

Nature medicine, 2001-03, Vol.7 (3), p.297-303

2001

Volltextzugriff (PDF)

Dendritic cell-based immunotherapy of cancer

Annals of oncology, 2000, Vol.11, p.199-205

2000

Volltextzugriff (PDF)

Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patients

Gene therapy, 2003-03, Vol.10 (5), p.386-395

2003

Volltextzugriff (PDF)

Thalidomide and venous thrombosis

Annals of internal medicine, 2002-05, Vol.136 (9), p.711

2002

Volltextzugriff (PDF)

Exosomes as Potent Cell-Free Peptide-Based Vaccine. II. Exosomes in CpG Adjuvants Efficiently Prime Naive Tc1 Lymphocytes Leading to Tumor Rejection

The Journal of immunology (1950), 2004-02, Vol.172 (4), p.2137-2146

2004

Volltextzugriff (PDF)

Exosomes in cancer immunotherapy: preclinical data

Advances in experimental medicine and biology, 2001, Vol.495, p.349

2001

Volltextzugriff (PDF)

Exosome-based immunotherapy

Cancer Immunology, Immunotherapy, 2004-03, Vol.53 (3), p.234-239

2004

Volltextzugriff (PDF)

Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma

Cancer research (Chicago, Ill.), 2001-09, Vol.61 (18), p.6838-6845

2001

Volltextzugriff (PDF)

Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitro

Cancer gene therapy, 1999-11, Vol.6 (6), p.564-571

1999

Volltextzugriff (PDF)

Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma

Cancer research (Chicago, Ill.), 2004-03, Vol.64 (6), p.2192-2198

2004

Volltextzugriff (PDF)

Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: Improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2

European journal of cancer (1990), 1994, Vol.30 (8), p.1078-1083

1994

Volltextzugriff (PDF)

In vitro generation of cytotoxic effectors activated by interleukin 2 (IL-2) : comparison of autologous peripheral blood stem cells (PBSC) from adults and children

Bone marrow transplantation (Basingstoke), 2001-04, Vol.27 (8), p.869-875

2001

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(67)

Sprache

Englisch
(61)
Französisch
(6)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immune-related adverse events with immune checkpoint blockade: a comprehensive review

Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer

Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours

Seeking the driver in tumours with apparent normal molecular profile on comparative genomic hybridization and targeted gene panel sequencing: what is the added value of whole exome sequencing?

Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety

Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy

Phase II trial of thalidomide in renal-cell carcinoma

Exosomes for cancer immunotherapy

Tumor-derived exosomes: a new source of tumor rejection antigens

FGFR inhibitor induced peripheral neuropathy in patients with advanced RCC

Cross-Presentation by Dendritic Cells of Tumor Antigen Expressed in Apoptotic Recombinant Canarypox Virus-Infected Dendritic Cells

Exosomes as Potent Cell-Free Peptide-Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I/Peptide Complexes to Dendritic Cells

Malignant effusions and immunogenic tumour-derived exosomes

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

Dendritic cell-based immunotherapy of cancer

Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patients

Thalidomide and venous thrombosis

Exosomes as Potent Cell-Free Peptide-Based Vaccine. II. Exosomes in CpG Adjuvants Efficiently Prime Naive Tc1 Lymphocytes Leading to Tumor Rejection

Exosomes in cancer immunotherapy: preclinical data

Exosome-based immunotherapy

Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma

Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitro

Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma

Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: Improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2

In vitro generation of cytotoxic effectors activated by interleukin 2 (IL-2) : comparison of autologous peripheral blood stem cells (PBSC) from adults and children

Aktive Filter

Suchergebnisse filtern